Form 4: Avita Medical's Chief Legal Officer, Nicole Kelsey, Acquires Stock Options
SEC Form 4 Filing
Nicole Kelsey, Chief Legal Officer of Avita Medical, Inc., reports the acquisition of 65,000 stock options on January 21, 2025.
Summary
- Nicole Kelsey, the Chief Legal Officer of Avita Medical, Inc., filed a Form 4 on January 22, 2025, reporting a transaction.
- On January 21, 2025, Ms. Kelsey acquired 65,000 stock options with an exercise price of $8.73.
- These options vest in three equal annual installments starting on the first anniversary of the grant date and expire on January 21, 2034.
- Following the reported transaction, Ms. Kelsey directly owns 65,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock option grants, so the sentiment is neutral.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders reporting transactions in their company's securities. It provides transparency to the market regarding insider activity.
Stakeholder Impact
- The acquisition of stock options by a key executive could be viewed positively by shareholders, as it aligns the executive's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of the stock option transaction. |
| 01/21/2025 | Date the stock options were granted. |
| 01/21/2034 | Expiration date of the stock options. |
| 01/22/2025 | Date the Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.